Q

Quanterix Corp
D

QTRX

2.97000
USD
-0.10
(-3.10%)
Market Open
Last updated: · Delayed 15 min
Volume
1,927
EPS
-2
Div Yield
-
P/E
-1
Market Cap
140,460,403
Overview
Related Instruments
ABT
ABT
D
Abbott Laboratories
104.975
0.170(0.16%)
AZN
AZN
D
AstraZeneca PLC
166.340
-0.470(-0.28%)
BNTX
BNTX
D
BioNTech SE American Depositary Share
88.500
-1.680(-1.86%)
GSK
GSK
D
GSK plc
49.650
0.630(1.29%)
JNJ
JNJ
D
Johnson & Johnson
256.48
3.44(1.36%)
MRK
MRK
D
Merck & Co
146.240
1.350(0.93%)
MRNA
MRNA
D
Moderna
211.820
-24.650(-10.42%)
N
NVAX
D
Novavax
11.610
-1.205(-9.40%)
PFE
PFE
D
Pfizer
29.485
0.110(0.37%)
REGN
REGN
D
Regeneron Pharmaceuticals
795.90
-0.80(-0.10%)
More

Title: Quanterix Corp

Sector: Healthcare
Industry: Medical Devices
Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.
Smarter Decisions,Together
FacebookTwitterYoutubeInstagramLinkedIn
App Store
iOS
Google Play
Android

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.